Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuhan Chemical Inc. is a prominent South Korean contract development and manufacturing organization (CDMO) and a wholly-owned subsidiary of Yuhan Corporation. Founded in 1980, the company specializes in the large-scale production of high-quality active pharmaceutical ingredients (APIs), advanced intermediates, and reference standard materials for the global pharmaceutical market. Yuhan Chemical operates two major cGMP-certified manufacturing sites in Ansan and Hwaseong, which are regularly inspected and approved by international regulatory agencies such as the US FDA, PMDA, and EDQM. The company is a strategic partner to several multinational pharmaceutical corporations, providing critical manufacturing support for blockbuster drugs in therapeutic areas including oncology, infectious diseases, and cardiovascular health. With a focus on technical excellence, Yuhan Chemical utilizes advanced technologies like flow chemistry and micronization to deliver complex small molecule solutions from clinical development through to commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuhan Chemical.